Does COMETRIQ Cause Malignant neoplasm progression? 16 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Malignant neoplasm progression have been filed in association with COMETRIQ. This represents 10.6% of all adverse event reports for COMETRIQ.
16
Reports of Malignant neoplasm progression with COMETRIQ
10.6%
of all COMETRIQ reports
13
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From COMETRIQ?
Of the 16 reports, 13 (81.3%) resulted in death, 3 (18.8%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for COMETRIQ. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does COMETRIQ Cause?
Off label use (75)
Fatigue (48)
Diarrhoea (39)
Stomatitis (29)
Nausea (23)
Death (20)
Decreased appetite (18)
Dry mouth (16)
Pain in extremity (16)
Dysgeusia (15)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which COMETRIQ Alternatives Have Lower Malignant neoplasm progression Risk?
COMETRIQ vs CONCERTA
COMETRIQ vs CONESTAT ALFA
COMETRIQ vs COPANLISIB
COMETRIQ vs COPAXONE
COMETRIQ vs COPEGUS